Global Lab Reach Clinysys serves over 4,000 labs across 39 countries, indicating a broad market footprint and potential for upsell across diverse regions and lab types, including healthcare, environmental, toxicology, crop science, and life sciences.

Leading Market Share Holding approximately 24% of the global lab informatics market (Signify Research, 2025), Clinisys demonstrates strong competitive positioning and a compelling case for expanding into biotech and pharma segments to capture adjacent growth.

Strategic Partnerships Recent collaborations with Decisions to enable low-code/no-code LIMS/LIS configuration and the Stockport NHS partnership highlight a channel-led growth strategy and opportunities to co-sell or implement configurable solutions for large lab networks.

AI and Governance Launch of CLS CARE, an AI assistant embedded in CLS for governance and documentation-grounded responses, signals a value proposition for labs seeking compliant AI workflows and could unlock opportunities in regulated environments and remote testing settings.

Industry Engagement Active sponsorships and conference participation (Bio-IT World Conference & Expo) combined with ongoing product expansions into physician offices, reference, and veterinary labs create avenues to target new segments, including healthcare providers and specialty labs, with scalable informatics solutions.